The ability of muscarinic cholinergic receptors to activate phosphoinositide turnover following agonistinduced internalization has been investigated. Incubation of SH-SY5Y neuroblastoma cells with oxotremorine-M resulted in a time-dependent endocytosis of both muscarinic receptors and a subunits of Gq and G 11, but not of isoforms of phosphoinositide-specific phospholipase C, into a subfraction of smooth endoplasmic reticulum (V1). Agonist-induced increases in diacylglycerol mass and in 32P-phosphatidate labeling, much of which was of the tetraenoic species, were also observed in the V 1 fraction, but these increases persisted when the agonist-induced translocation of receptors into the V1 fraction was blocked. All enzymes of the phosphoinositide cycle were detectable in the V1 fraction. However, with the exception of phosphatidylinositol 4-kinase, none was enriched when compared with cell lysates. Both 32P-labeling studies and enzyme assays point to a very limited capacity of this fraction to synthesize phosphatidylinositol 4,5-bisphosphate, whereas the synthesis of phosphatidylinositol 4-phosphate is robust. These results indicate that endocytosed receptors do not appear to retain their ability to activate phosphoinositide turnover. The availability of the substrate for phospholipase C, phosphatidylinositol 4,5-bisphosphate, may be one factor that limits the activity of muscarinic receptors in this subcellular compartment. Key Words: G~q 1ii-PhosphoIipaseC isozymes-Diacylglycerol-Phosphatidylinositol 4-phosphate 5-kinase-Lipid substrate availability-Phosphatidate.
Abstract:
The ability of muscarinic cholinergic receptors to activate phosphoinositide turnover following agonistinduced internalization has been investigated. Incubation of SH-SY5Y neuroblastoma cells with oxotremorine-M resulted in a time-dependent endocytosis of both muscarinic receptors and a subunits of Gq and G 11, but not of isoforms of phosphoinositide-specific phospholipase C, into a subfraction of smooth endoplasmic reticulum (V1). Agonist-induced increases in diacylglycerol mass and in 32P-phosphatidate labeling, much of which was of the tetraenoic species, were also observed in the V 1 fraction, but these increases persisted when the agonist-induced translocation of receptors into the V1 fraction was blocked. All enzymes of the phosphoinositide cycle were detectable in the V1 fraction. However, with the exception of phosphatidylinositol 4-kinase, none was enriched when compared with cell lysates. Both 32P-labeling studies and enzyme assays point to a very limited capacity of this fraction to synthesize phosphatidylinositol 4,5-bisphosphate, whereas the synthesis of phosphatidylinositol 4-phosphate is robust. These results indicate that endocytosed receptors do not appear to retain their ability to activate phosphoinositide turnover. The availability of the substrate for phospholipase C, phosphatidylinositol 4,5-bisphosphate, may be one factor that limits the activity of muscarinic receptors in this subcellular compartment. Key Words: G~q 1ii-PhosphoIipaseC isozymes-Diacylglycerol-Phosphatidylinositol 4-phosphate 5-kinase-Lipid substrate availability-Phosphatidate. J. Neurochem. 68, 1473-1483 (1997) .
The internalization (sequestration) of receptors present at the cell surface into a membrane fraction that exhibits a lower density than that of the plasma membrane and is inaccessible to hydrophilic ligands is an adaptive response to the prolonged agonist occupancy of muscarinic cholinergic receptors (mAChRs) in neural tissues (Fiegenbaum and El-Fakahany, 1985; Harden et al., 1985; Thompson and Fisher, 199] ). Although the agonist-induced endocytosis of cell surface receptors via caveolae and/or clathrin-coated pits has been reported (Garland et al., 1994; Roettger et al., 1995) , results from our laboratory with human SH-SY5Y neuroblastoma indicate that mAChRs in this cell line are internalized predominantly via a clathrinmediated mechanism (Slowiejko et al., 1996) . SH-SY5Y cells express a relatively high density of mAChRs (20,000-30,000/cell) of the m3 subtype, which couple to the G~1111-mediatedactivation of phosphoinositide-specific phospholipase C (PLC), with the subsequent hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2), formation of inositol 1 ,4,5-trisphosphate, and rise in the concentration of intracellular Ca 2~ (Lambert and Nahorski, 1990; Fisher et al., 1994; Slowiejko et al., 1994) . In a previous study with the parent SK-N-SH cell line, we observed that when internalized mAChRs were prevented from recycling to the cell surface by the use of a low-temperature paradigm, there was a pronounced reduction in the magnitude of mAChR-stimulated phosphoinositide hydrolysis in response to the addition of either hydrophilic or lipophilic agonists (Thompson and Fisher, 1991) . These results led us to the conclusion that mAChRs localized at the plasma membrane were preferentially coupled to PLC activation. One possible explanation for these results is that the agonist-induced phosphorylation of cell surface mAChRs (Tobin and Nahorski, 1993; Tobin et al., 1996) results in both their internalization and their uncoupling from PLC. However, the relationship between phosphorylation of the mAChR, receptor internalization, and functional uncoupling has yet to be established, and other explanations for the apparent inability of endocytosed mAChRs to activate PLC need to be considered. In fact, the issue of whether the internalization of receptors results in their uncoupling from PLC remains to be established. In this context, it should be noted that, in addition to mAChRs, both Gq and PLC are present in subcellular fractions derived from the endocytic pathway (Harden et al., 1985; Martin et al., 1991; Svoboda and Milligan, 1994) . Moreover, in these same fractions, the addition of guanine nucleotides can regulate both PLC activity and the affinity with which agonists bind to mAChRs (Harden et al., 1985; Martin et al., 1991) . In addition, dopamine D 1, dopamine D2, and adenosine A1 receptors have been shown to retain their ability to modulate adenylyl cyclase activity when present in clathrincoated vesicle fractions (Gonzalez-Calero et al., 1990; Ozaki et al., 1994) . Evaluation of whether phosphoinositide-linked receptors can activate PLC at subcellular locations other than at the plasma membrane is made difficult by the factthat the extent of agonist-stimulated PLC activity, even if detectable, is substantially reduced when monitored in cell-free preparations. In addition, to date there has been no systematic study of the enrichment of the individual components of the phosphoinositide-signaling pathway (i.e., G~1, PLC, and the enzymes of phosphoinositide turnover) in the cellular compartment into which cell surface receptors are endocytosed.
In the present study, we have addressed the functional status of internalized mAChRs in SH-SY5Y cells after the isolation of a subcellular fraction (V1) that is enriched in endocytosed receptors. The following questions have been addressed: (1) Do other components of the phosphoinositide-signaling pathway also undergo endocytosis in response to mAChR activation? (2) Are all of the enzymes necessary for operation of the phosphoinositide cycle present in this endocytic fraction? The results indicate that although all enzymes of the phosphoinositide cycle can be detected in VI, most are not enriched, and the ability of this fraction to synthesize PIP2 is very limited. However, the a subunits of Gq and G11 (but not PLC or other enzymes of phosphoinositide turnover) undergo endocytosis along with the mAChR after exposure of the cells to muscarinic agonists. Although increases in sn-1 ,2-diacylglycerol (DAG) mass and [ 32PI phosphatidic acid ([32P] PA) labeling are observed in the subcellular fraction enriched in endocytosed mAChRs, the increases in lipid turnover persist when receptor translocation is blocked. These results suggest that when mAChRs are endocytosed they lose their ability to activate PLC and that a determining factor in this loss of responsiveness may be a limited substrate availability. A preliminary account of part of this study has previously been reported (Sorensen et al., 1997) . [N-methyl - were routinely grown in tissue culture flasks (75 cm 2/250 ml) in 20 ml of Dulbecco's modified Eagle's medium supplemented with 10% (by volume) fetal calf serum. Cells were grown for 7-14 days at 37°Cin an atmosphere consisting of 10% CO 2 and 90% humidified air. Cells were isolated after aspiration of the medium and incubation with a modified Pucks D1 solution (Honneger and Richelson, 1976) . Cells were then resuspended in buffer A (142 mM NaC1, 5.6 mM KC1, 2.2 mM CaCl2, 3.6 mM NaHCO~,1 mM MgCl2, 5.6 mM Dglucose, and 30 mM HEPES, pH 7.4).
MATERIALS AND METHODS

Cell culture conditions
Subcellular fractionation
A modified procedure of the method of Strader et al. (1984) was used to obtain crude plasma membrane (P1) and "light" membrane (V1) fractions as previously described (Slowiejko et al., 1996) . The high-speed supernatant fraction (S2) was also retained for assay. In some experiments, the V1 fraction was applied to a discontinuous density gradient consisting of 60, 48, and 35% (wt/vol) 
Radioligand binding
Whole cell lysates and subcellular fractions of SH-SY5Y cells were resuspended in KGEH buffer (139mM potassium glutamate, 4 mM MgCI2, 10 mM EGTA, and 30 mM HEPES, pH 7.4). Fractions were then incubated with either 6 nM [ 3H]NMS, I nM [3H]QNB, or 6 nM [3Hiscop-olamine at 37°Cfor 90 mm. These concentrations of radioligands are sufficient to occupy >90% of mAChR sites in lysates and subcellular fractions. Nonspecific binding was determined as that unaffected by inclusion of 25~sMatro-pine. Reactions were rapidly terminated by filtration through Whatman GF/B glass-fiberfilters and radioactivity was determined after the addition of 5 ml of Universol scintillation fluid.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
Aliquots (25~.tg)of whole cell lysates or subcellular fractions of SH-SY5Y cells were boiled in SDS-PAGE sample buffer for 5 mm and electrophoresed through 10% SDSpolyacrylamide gels (Laemmli, 1970) . Proteins were transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Bedford, MA, U.S.A.) and processed for immunoblot analysis. It should be noted that the separation of some protein isoforms (including G,~1
and~is facilitated by the presence of sodium tetradecyl sulfate present in commercially available SDS (see Siegel and Desmond, 1989) .
Western blot analysis
Nonspecific binding sites were blocked in phosphate-buffered saline (pH 7.4) containing 0.1% Tween 20 (PBS-T) and 1% bovine serum albumin for 1 h at room temperature. Primary antibodies were diluted in blocking solution (final concentration, 0.1-0.5 ,ug/m]) and incubated with the membranes for 1 h. Excess primary antibody was removed by washing the membranes three times in PBS-T. The blots were then incubated in the appropriate peroxidase-conjugated secondary antibody diluted in PBS-T (1:10,000) for I h and subsequently washed three more times in PBS-T. Immunoreactive proteins were detected by ECL. Membranes were reprobed after stripping in 0.1 M Tris-HC1 (pH 8.0), 2% SDS, and 100 mM~-mercaptoethanol for 30 mm at 52°C. The blots were rinsed two times in PBS-T and processed as above with a different primary antibody. Quantitative analysis of autoluminograms was performed by computer-assisted imaging densitometry (MCID, Imaging Research, St. Catharines, Ontario, Canada). The assignment of specific bands as G~qand G~11,which were detected with the same antibody, was performed based on reported electrophoretic mobilities.
32P-Phospholipid labeling
Aliquots of P 1 and V1 fractions (100-400~ig of protein) were resuspended in 150~tl of KGEH buffer (free Ca 2~,50 nM). Reactions were initiated by the addition of 100~il
[22PIATP (final concentration, 50 tiM; sp. act. 2.5-4.5
x l0~cpm/nmol) and allowed to continue for the times indicated (0-5 mm at 37°C).In some experiments, the concentration of ATP was increased to 200 ftM to ensure that its availability was not a rate-limiting factor. Reactions were terminated by the addition of 0.75 ml CFICI 2/CH3OH (1:2).
Lipids were extracted, separated, and quantitated as previously described (Fisher et al., 1984) .
Argentation TLC
PA formed from the 32P-phospholipid-labeling experiment was isolated and extracted from the silica gel with three 1.0-ml aliquots of CHCl 3/CH~OH/HCl (1:2:0.05). The combined extracts were washed with 2.0 ml CHC11/CH3OH/ H2O (3:48:47) and blown to dryness under N2. PA was methylated with excess diazomethane (Fales et al., 1973) and separated according to degree of unsaturation on 40% (wt/wt) silver nitrate-impregnated TLC plates as outlined by Van Rooijen et al. (1985) .
DAG mass
The mass of DAG present in aliquots of intact cells and Pi or V1 fractions (100-300 pg of protein) was monitored by the method of Preiss et al. (1986) , after initial lipid extraction (Fisher and Agranoff, 1980) . DAG standards (100-1,000 pmol) were routinely run in parallel.
DAG kinase
Activity was monitored by the method of Besterman et al. (1986) , with the exceptions that the incubation time was reduced to 2 mm and the concentration of ATP increased to 300 1iM.
PLC
Activity was monitored using [ 3H]PIP as substrate. Assays were performed in a final volume of 100~.cl containing 10 mM HEPES (pH 7.4), 120 mM KCI, 10 mM NaC1, 2 mM EGTA, 2.2 mM CaC1,, 6.0 mM MgC1 2, and 0.5% sodium cholate. The final concentration of [ 2HIPIP was 50 fLM (~-20,000dpm) and the lipid was added after having been blown down under N 2 and sonicated in 10 mM HEPES (pH 7.4) buffer. Reactions were allowed to proceed for 5 mm at 30°Cand were terminated by the addition of 0.375 ml CHCl~/CH~OH/HCl (20:40:1), followed by 0.125 ml CHCI3 and 0.125 ml 0.1 M HCI. Radioactivity was then quantitated after the addition of 5 ml of Universol scintillation fluid to a 0.2-ml aliquot of the upper phase.
CDP-DAG synthase
Activity was measured as previously described by Sparrow and Raetz (1985) and Kelley and Carman(1987) . Aliquots of whole cell lysates, and P1 or V1 fractions (40-100 pg of protein), were incubated for 10 mm at 37°Cin 50mM Tris-maleate buffer (pH 6.5), 1 mM PA, 20 mM MgCI2, 1 mg/mi bovine serum albumin, and 1 mM [y32PIdCTP (22,000 cpmlninol) in a final volume of 200 p1. Reactions were terminated by the addition of 1.7 ml CHCl~/CH 3OH (1:2) and lipids extracted after the addition of 0.5 ml 1.2 M HC1 and 1.0 ml CHCI5. The lower phase was washed twice with 2 ml of acidified Foich upper phase and radioactivity present in I .0-mi aliquots of the organic phase determined.
P1 synthase
Activity was monitored by the method of Fischl and Carman (1983) , as modified by Heacock et al. (1993) , with the exceptions that MnC12 was excluded and the final concentration of inositol was 1 mM (22,000 cpm/nmol).
P1 and PIP kinase
Activities were measured as previously described by MacDonald et al. (1987) .
Other measurements
NADPH-cytochrome c reductase activity was measured spectrophotometrically at room temperature by the method of Sotocassa et al. (1967) . [ 3HlOuabainbinding was determined by the method of Svoboda and Milligan (1994) . Protein content was measured with the Pierce BCA protein assay reagent (Rockford, IL, U.S.A.).
Data analysis
Results given are mean ± SEM values for the number (n) of separate experiments performed. For every parameter monitored, duplicate or triplicate replicates were obtained.
Student's two-tailed t tests were used to evaluate the statistical differences of the means of paired or unpaired sets of data.
RESULTS
Agonist-induced subcellular redistribution of cell surface mAChRs
Evaluation of the functional status of internalized mAChRs required the isolation of a subcellular fraction from SH-SY5Y cells in which sequestered mAChRs were concentrated and one that yielded sufficient material for biochemical studies. Initial attempts to obtain such a fraction after the application of hypotonic cell lysates to continuous or discontinuous sucrose density gradients were unsuccessful due to the limited degree of enrichment of mAChRs obtained in any single fraction. A more effective separation of internalized mAChRs was obtained using a modification of the differential centrifugation procedure of Strader et al. (1984) . Using this approach, a redistribution of mAChRs from a crude plasma membrane fraction (P 1) into a light vesicular fraction (V1), which sedimented at 200,000 g for 90 mm was observed when intact SH-SY5Y cells were incubated with Oxo-M for 30 mm at 37°C.Whereas only 3% of total mAChRs recovered were located in the V1 fraction obtained from quiescent cells, this value increased to 16% upon exposure of cells to Oxo-M (500 ±73% of control, n = 5, Table   1 ). This appearance of mAChR binding sites in the V1 fraction was accompanied by a corresponding loss of [ 3H}QNB binding sites from the P 1 fraction. Marker analysis indicated that <2% of [ 3Hjouabain binding (a measure of plasma membrane Na~,K~-ATPase) was recovered in the V 1 fraction and that this distribution was unaltered by the addition of agonist. Although the P1 fraction possessed the majority of the NADPHcytochrome c reductase activity (a marker for smooth endoplasmic reticulum; Table I ), significant amounts of this enzyme (35-41%) were recovered in the V1 fraction, indicating that the latter represents, in part at least, a subfraction of the smooth endoplasmic reticulum. No subcellular redistribution of NADPH-cytochrome c reductase activity occurred after exposure of the cells to Oxo-M. In some experiments, the V1 fraction was applied to a discontinuous sucrose gradient consisting of 35, 48, and 60% sucrose and centrifuged at 150,000 g for 90 mm to further fractionate V1. After density gradient centrifugation, >90% of mAChRs and protein recovered were located at the 0-35% sucrose interface (V2), an equilibrium density at which internalized mAChRs, /32-adrenergic, and transferrin receptors have previously been observed (Harden et al., 1985; Lohse et al., 1990; Sillence and Downes, 1993) . Because the agonist-induced increases in mAChR density in the V2 fraction obtained from SH-SY5Y cells (430-650% of control) were comparable with those observed for the V1 fraction (see Table 1 ), the latter was used for all subsequent experiments.
In intact cells, when monitored as the loss of [ 3HI-NMS binding sites, 30-40% of cell surface mAChRs are sequestered upon the addition of Oxo-M (Slowiejko et al., 1996), whereas <20% of receptors are recovered in the V 1 fraction by using the fractionation paradigm. Thus, to determine whether the subcellular redistribution of mAChRs into the V1 fraction was representative of sequestration events monitored in intact cells, the characteristics of this agonist-mediated translocation of mAChRs were further examined. The appearance of mAChRs in the V 1 fraction was time dependent with the onset detectable within 5 mm of
Oxo-M addition and the maximal effect observed after 30-60 mm (t112 = 12 mm; Fig. IA) , results comparable with those previously observed for receptor sequestration in intact SH-SY5Y cells Slowiejko et al., 1994) . The appearance of mAChRs in the V1 fraction also displayed a similar dependence on agonist concentration and efficacy to that observed for sequestration in intact cells. Thus, half-maximal translocation was observed at a 3-10 assayed at 37°C (Fig. IB) . Taken collectively, the results indicate that although fewer mAChRs are recovered in the V 1 fraction than are "lost" from the surface of intact SH-SY5Y cells, the characteristics of mAChR translocation into the V1 fraction resemble those observed for receptor sequestration in intact cells in terms of kinetics, agonist concentration dependence, and agonist efficacy. Furthermore, it is apparent that the V1 fraction is enriched in endocytosed mAChRs that are readily recognized by lipophilic, but not hydrophilic, ligands.
G,~qand G~11are endocytosed with the mAChR
The subcellular distribution of G0~10 and Gu, in control and Oxo-M-pretreated cells was determined by western blot analysis and quantitative densitometry ( Fig. 2A) . In control cells, all three subunits analyzed were significantly enriched in the P1 fraction compared with whole cell lysates (359 ±50, 236 ±7, and 219 ±31%, for G04, G~11,and G~,respectively, n = 4). In contrast, there was little immunoreactivity associated with G,,~1, G011, orG~,in the V1 fraction (13 ±6, 11 ±5, and 21 ±9% of lysate values, respectively, n = 4). The a subunits of all three G proteins were essentially absent from the S2 fraction. SH-SY5Y cells were incubated in the absence or presence of I mM Oxo-M for 30 mm and then sub jccted to hypotonic lysis and differential centritugation. Cell lysates, P1. V~,and S2 fractions were then assayed for enzyme activity. Results shown are mean ±SEM values for three to live separate experiments. Relative specific activity = aclivity of enzyme in a subcellular fraction/activity of enzyme in whole cell lysate.
(177 ± 35 and 201 ± 60% of control, respectively, n = 4, p <0.05) and a 14-15% decrease in P1 immunoreactivity. In contrast, no reduction in immunoreactivity of G,,~1and G,~11was detected in whole cell lysates obtained from cells incubated with Oxo-M. In addition, no increase in G,,. immunoreactivity in the V1 fraction was observed after agonist pretreatment. To further evaluate the specificity of Oxo-M-induced changes in G,,~11,~11 and Gu5, intact cells were incubated with Oxo-M for 24-48 h. Under these conditions, immunoreactivity of Guq and Gu11 in whole cell lysates was reduced by 71 ± 16 and 49 ±16%, respectively (n = 4). In contrast, a significantly smaller decrease in G,~, immunoreactivity (26 ± 7%) was observed (Fig. 2B) . The distribution of G4 was also determined in the subcellular fractions. Although the P1 fraction was the most enriched compared with cell lysates (166 ± 8%, n = 5), significant immunoreactivity was also associated with the V1 fraction (68 ± 3%, n = 5). No increase in Gĩmmunoreactmvity in the V1 fraction was observed after exposure of the cells to Oxo-M for 30 mm.
Subcellular distribution of PLC isozymes
PLC present in intact cells and subcellular fractions was determined either by means of measurement of the release of labeled inositol phosphates or after western blot analysis and quantitative densitometry. When assessed using exogenously added [ 3HIPIP as substrate, most of the PLC activity (76-77%) was recovered in the S 2 fraction with much less activity localized to the P1 fraction (19%). Five percent or less of PLC activity was recovered in the V1 fraction (relative sp. act. 0.29-0.42; Table 2 ). No significant changes in the activity or distribution of PLC occurred after Oxo-M pretreatment. Because individual PLC isozymes may be differentially localized within the cell, the subcellular distributions of PLC-N I (primarily a~1-linked), PLC-~3(a~1and ny-linked), and PLC-yI (linked to receptor tyrosine kinases) were evaluated by western blot analysis (Fig. 3) . PLC-~lwas enriched in the P fraction (180 ±22% of that present in cell lysate, n = 4) but not in either the V1 or the S2 fractions (50 ± 4 and 11 ± 3%, respectively, n = 3). PLC-~3was significantly more enriched in the V fraction (210 ± 31% of that present in cell lysates, n = 5) than in the P1 fraction (125 ±11%, n = 5), whereas much less immunoreactivity was observed in the S2 fraction (27 ± 2%, n = 5). In contrast, PLC-yl was most enriched in the S2 fraction (677 ±64% of cell lysate, n = 3). PLC-'yl immunoreactivity in the V1 fraction equaled that present in the cell lysate (120 ± 35%, n = 3) but was virtually absent from the P1 fraction ( 10   FIG. 3 . Western blot analysis of PLC-~31, in subcellular fractions derived from control or Oxo-M-pretreated cells. Experimental conditions were as described in the legend to Fig. 2A and antibodies to PLC-/Il, PLC-/I3, and PLCyl were used at final concentrations of 0.25, 0.1, and 0.1 jig! ml, respectively. Results shown are representative of those obtamed in three or four separate experiments.
I. Ncurcs hell?., Vol. 68, No. 4, /997 ±5% of cell lysate, n = 4). No statistically significant changes in the subcellular distribution of either PLC31or yl were detected in response to Oxo-M pretreatment of cells, whereas a small but statistically significant reduction (14%) in the distribution of PLC-f33 was observed for the V 1 fraction (Fig. 3) .
DAG availability, PA formation, and metabolism
After the activation of PLC-linked receptors in intact cells, increases in DAG availability and PA formation are consistently observed. To determine whether these changes are also evident in the cellular compartment enriched in endocytosed mAChRs, DAG mass and PA formation were monitored in subcellular fractions obtained from both control and Oxo-M--treated cells. The concentration of DAG in the V1 fraction obtained from control cells was relatively low (24% of that present in the P1 fraction, see Table 3 ). When the same V1 fraction was incubated in an "intracellular-like" KGEH buffer that contained [ 32P]ATP, the [32P]PA labeling observed was also <20% of that obtained for the P 1 fraction (Fig. 4A) . SH-SY5Y cells were incubated for 30 mm in the absence or presence of I mM Oxo-M. Cells were then lysed and subjected to differential centrifugation. Aliquots of either intact cells or P~or V1 fractions were then assayed for DAD mass, as described in MaterIals and Methods. Results shown are means ± SEM for four separate experiments.
Different from control, p < (1.05.
uted to the restricted availability of DAG, rather than a low activity of DAG kinase, because both P1 and V1 fractions possessed similar activities of this enzyme (Table 2) . To determine the molecular species of PA formed (and hence, the source of DAG backbone), the 32P I PA was methylated and subjected to argentation TLC (Van Rooijen et al., 1985; see Fig. 5 ). Under basal conditions, much of the [32P]PA label (in both V 1 and P1 fractions) was present in the mono-and dienoic forms, whereas <20% was recovered in the tetraenoic species (indicative of an inositide origin). When the cells were exposed to Oxo-M, significant increases in the concentration of DAG were observed in intact cells and P1 and V1 fractions (Table 3) . The attendant increase in [ 32PIPA labeling, which was most evident for the V 1 fraction (212 ±20% of control, n = 11), reflected this increased availability of DAG (Fig. 4B) . Analysis of the newly formed [ 22P]PA indicated that approximately half was of the mono-and dienoic species, with the remainder recovered as either the tetra-or pentaenoic species. Increases in the labeling of the tetraenoic species of PA were significantly greater in the V 1 fraction (680 ± 29%) than in the P1 fraction (385 ±26% of control,p < 0.05). In contrast, no significant differences in the labeling of the other molecular species of PA in the P1 and V1 fractions were observed (Fig. 5) . The V1 fraction also possesses the potential for the further conversion of PA into CDP-DAG, because CDP-DAG synthase activity was detected in this fraction (Table 2) .
To determine whether the agonist-mediated increase in DAG accumulation and PA formation reflected the activation of mAChRs that had been endocytosed into the V1 fraction, cells were made hypertonic (600 mOsm) by the addition of sucrose, a condition under which the agonist-induced translocation of mAChRs is essentially abolished (Fig. 6 ; see Slowiejko Ct al., 
Inositol lipid substrate availability
Whether the availability of inositol lipid substrate is a factor that limits the ability of endocytosed mAChRs to activate PLC was assessed by 32P-metabolic labeling studies and by direct measurement of the relevant enzyme activities. When P 1 and V1 fractions obtained from control SH-SY5Y cells were incubated in KGEH buffer with [ 32P]ATP, >70% of the radiolabel present in the lipid fraction was recovered in PIP 2 and PIP at all incubation times. However, pronounced differences in the 32P-labeling of the polyphosphoinosi- (Fig. 7C) . Consistent with the observations made from the metabolic labeling studies, there were pronounced differences in the subcellular distribution of three key enzymes of inositol lipid synthesis, namely, P1 synthase, P1 kinase, and PIP kinase (Table  2) . Neither P1 synthase nor PIP kinase was enriched in the V1 fraction (relative sp. act. -=0.8 and 0.50, respectively), both of these enzymes being recovered predominantly in the P1 fraction. In marked contrast, 37-39% of P1 kinase activity recovered was present in the V1 fraction (relative sp. act. '-2.2), an observation consistent with the enhanced 32P-labeling of PIP in this . 1. Neurochem., Vol. 68, No. 4, 1997 Table 2) .
DISCUSSION
In the present study, evaluation of a possible functional role for internalized mAChRs in SH-SY5Y cells has been facilitated by the isolation of a subcellular fraction (V1) that is enriched in endocytosed receptors. Previously, a "light vesicle" fraction obtained after density gradient centrifugation of whole cell lysates has been used to monitor the subcellular localization of internalized cell surface receptors (Waldo et al., 1983; Harden et al., 1985; Lohse et al., 1990; Sillence and Downes, 1993; Svoboda and Milligan, 1994) . Although both the V1 and light vesicle fractions are heterogeneous, the use of a differential centrifugation procedure to obtain V1 results in the isolation of an endocytic fraction that is recovered more rapidly and in better yield. Moreover, the characteristics of the V1 fraction and light vesicle fractions are similar. For example, the V1 fraction (1) demonstrates a comparable degree of enrichment of mAChRs (four-to fivefold) upon agonist addition, (2) is enriched in smooth endoplasmic reticulum, (3) is essentially devoid of plasma membrane, and (4) exhibits similar equilibrium density characteristics as the light vesicular fraction when applied to sucrose density gradients. In addition, radioligand binding studies indicate that mAChRs in the V1 fraction are relatively inaccessible to hydrophilic ligands, which suggests that receptors are present in endocytic "inside-out" vesicles. Although fewer mAChRs are recovered in the V1 fraction than are lost from the cell surface of intact cells, the characteristics of mAChR translocation into this subcellular fraction resemble those observed for receptor sequestration in intact cells in terms of kinetics and dependence on agonist concentration and efficacy.
For internalized mAChRs to activate PLC, both G~1
and PLC must be present in the same endosomal compartment. Although relatively little G011 and G,~11are present in the V1 fraction obtained from quiescent cells (-2-3% of total), this value increases to 4-6% upon exposure of the cells to Oxo-M, whereas no statistically significant increase in immunoreactivity associated with either G0, or G4 (of which 14% of the cellular complement is localized to V1) was observed for the same fraction. A similar agonist-induced translocation of the a subunits of G~1and G11 has previously been reported for Chinese hamster ovary cells transfected with the cDNA for the m1 mAChR (Svoboda and Milligan, 1994) , although in the latter study an agonist-induced translocation of G,~,was also observed. The endocytosis of Guq and G1~in SH-SY5Y cells in response to Oxo-M addition could indicate either a functional role for the G protein in the sustained coupling of internalized mAChRs to PLC or, alternatively, the intracellular targeting of these subunits before lysosomal degradation. Consistent with the latter possibility is the observation that Guq, Gui1, and mAChRs all undergo down-regulation in response to chronic mAChR activation, whereas G~1.is much less affected (Fig. 2B) . The reductions in G,~q/Go11immunoreactiv-ity (49-71%) were similar in magnitude to the loss of mAChRs (52%; see legend to Fig. 2 ). This observation is consistent with previous studies that indicate that both PLC-coupled wild-type receptors and Gq undergo down-regulation at approximately the same rate (Milligan et al., 1996) . Relatively little functional PLC activity (--5% of total) was recovered in the V1 fraction and western blot analysis confirmed the relative deficiency of the isoform of PLC (131), which is considered to be primarily linked to Goq/G,~ii.Unexpectedly, however, appreciable PLC-/33 and PLC-yl immunoreactivity was found to be associated with the V1 fraction. Although the significance of the latter finding is presently unclear, the results could suggest that PLC functional activity is highly regulated in this fraction.
In contrast to the results obtained for Guq and Gui1, no translocation of any of these three isoforms of PLC into the V 1 fraction was observed after agonist addition.
Although neither G,,q/G11it nor PLC-/31 is abundant in V1, substantial increases in DAG mass and~3 Thus, it is more likely that DAG formation occurs primarily at a site other than the V1 fraction (presumably the plasma membrane) and that a redistribution of at least some of this lipid to the endosomal compartment (and its phosphorylation to PA) occurs thereafter.
Although increases in phosphoinositide hydrolysis may occur primarily at subcellular location(s) other than the V1 fraction, the products of phosphoinositide turnover may nonetheless play an important role in the intracellular trafficking of mAChRs. For example, increases in DAG concentration have been demonstrated to promote membrane fusion (Siegel et al., 1989; Sánchez-Migallón et a!., 1994). Furthermore, the formation of PIP has also been linked to membrane fusion and intracellular trafficking events (Del Vecchio and Pilch, 1991) .
We have previously calculated that for continuous mAChR-stimulated phosphoinositide hydrolysis to occur in SH-SY5Y cells, the entire PIP2 pool must be replenished every 45-60 s . This prompted an examination of the ability of the V1 fraction to synthesize phosphoinositides. Although all of the enzymes necessary for the breakdown and resynthesis of inositol lipids can be detected, the most pronounced observation was the relative inability of the V1 fraction to synthesize PIP2, as was apparent from both 32P-labeling studies and direct enzyme measurement. Because PIP formation occurs readily in this fraction, precursor availability is unlikely to be a ratelimiting factor in PIP 2 synthesis. In addition, because PIP kinase activity in SH-SY5Y cells is recovered predominantly in the particulate fractions (as previously observed for C6 glioma cells; see Morris et al., 1990) , it is unlikely that, in the intact cell, the cytosol would provide a significant source of the enzyme. Accordingly, it is conceivable that the limited ability of the V fraction to synthesize PIP2 may represent one of the key factors that prevents the sustained coupling of endocytosed mAChRs to PLC. The low activities of both PIP and DAG kinases in the V1 fraction, along with the enrichment of P1 kinase, is strikingly reminiscent of the distribution of these same enzymes in glucose transporter-containing vesicles and clathrincoated vesicles (Campbell et al., 1985; Del Vecchio and Pilch, 1991) and raises the possibility that this enzyme profile may be functionally relevant in structures dedicated to intracellular trafficking.
In summary, although all components necessary for operation of the phosphoinositide cycle can be detected in the endocytic fraction into which mAChRs are endocytosed, the major conclusion to emanate from the present study is that once internalized, mAChRs appear to possess little, if any, potential to further activate PLC. One factor that may explain the refractoriness of internalized receptors to activate PLC is the very limited capacity of this endocytic fraction to synthesize the primary lipid substrate PIP2.
